Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Willems

Showing results (691-700 of 794) with videos related to

Pageof 80
Sort By:
Pigment Cell & Melanoma Research|December 18, 2014
Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenibMarlous Hoogstraat, Christa G Gadellaa-van Hooijdonk, Inge Ubink, et al.
Breast Cancer Research and Treatment|October 12, 2012
Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trialE L Postma, H M Verkooijen, S van Esser, et al.
Orphanet Journal of Rare Diseases|June 3, 2021
Direct and indirect costs and cost-driving factors in adults with tuberous sclerosis complex: a multicenter cohort study and a review of the literatureJohann Philipp Zöllner, Janina Grau, Felix Rosenow, et al.
Scientific Reports|December 3, 2017
Combined genetic approaches yield a 48% diagnostic rate in a large cohort of French hearing-impaired patientsD Baux, C Vaché, C Blanchet, et al.
Plos One|May 25, 2019
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancerWillemijn S M E Theelen, Thomas Kuilman, Katja Schulze, et al.
Free Radical Biology & Medicine|June 19, 2022
The decylTPP mitochondria-targeting moiety lowers electron transport chain supercomplex levels in primary human skin fibroblastsElianne P Bulthuis, Claudia Einer, Felix Distelmaier, et al.
Oral Oncology|June 19, 2018
Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glandsE Boon, M H Valstar, W T A van der Graaf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 25, 2024
Improved delineation with diffusion weighted imaging for laryngeal and hypopharyngeal tumors validated with pathologyHilde J G Smits, Cornelis P J Raaijmakers, Mischa de Ridder, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 13, 2021
Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm studyM Luu, P Vabres, H Devilliers, et al.
Cancers|October 13, 2021
SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic TargetOscar Emanuel, Jacklyn Liu, Volker H Schartinger, et al.
Pageof 80

Showing results (691-700 of 794) with videos related to

Sort By:
Pageof 80
Pigment Cell & Melanoma Research|December 18, 2014
Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenibMarlous Hoogstraat, Christa G Gadellaa-van Hooijdonk, Inge Ubink, et al.
Breast Cancer Research and Treatment|October 12, 2012
Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trialE L Postma, H M Verkooijen, S van Esser, et al.
Orphanet Journal of Rare Diseases|June 3, 2021
Direct and indirect costs and cost-driving factors in adults with tuberous sclerosis complex: a multicenter cohort study and a review of the literatureJohann Philipp Zöllner, Janina Grau, Felix Rosenow, et al.
Scientific Reports|December 3, 2017
Combined genetic approaches yield a 48% diagnostic rate in a large cohort of French hearing-impaired patientsD Baux, C Vaché, C Blanchet, et al.
Plos One|May 25, 2019
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancerWillemijn S M E Theelen, Thomas Kuilman, Katja Schulze, et al.
Free Radical Biology & Medicine|June 19, 2022
The decylTPP mitochondria-targeting moiety lowers electron transport chain supercomplex levels in primary human skin fibroblastsElianne P Bulthuis, Claudia Einer, Felix Distelmaier, et al.
Oral Oncology|June 19, 2018
Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glandsE Boon, M H Valstar, W T A van der Graaf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 25, 2024
Improved delineation with diffusion weighted imaging for laryngeal and hypopharyngeal tumors validated with pathologyHilde J G Smits, Cornelis P J Raaijmakers, Mischa de Ridder, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 13, 2021
Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm studyM Luu, P Vabres, H Devilliers, et al.
Cancers|October 13, 2021
SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic TargetOscar Emanuel, Jacklyn Liu, Volker H Schartinger, et al.
Pageof 80